GIC
TEVA icon

Generali Investments CEE’s Teva Pharmaceuticals TEVA Stock Holding History

Generali Investments CEE’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$691K Hold
20,400
– – 0.03% 332
2026
Q1 		$614K Hold
20,400
– – 0.03% 336
2025
Q4 		$637K Hold
20,400
– – 0.04% 284
2025
Q3 		$412K Hold
20,400
– – 0.03% 310
2025
Q2 		$342K Hold
20,400
– – 0.03% 308
2025
Q1 		$314K Hold
20,400
– – 0.03% 309
2024
Q4 		$450K Buy
+20,400
New +$371K 0.05% 264

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Generali Investments CEE's TEVA Position: Q2 2026 in Review

Generali Investments CEE held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 20,400 shares worth $691K. The position accounts for 0.03% of the portfolio, ranked #332.

Generali Investments CEE first reported a position in TEVA in Q4 2024 and has held it in 7 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Generali Investments CEE held 20,400 shares of Teva Pharmaceuticals worth $691K as of Q2 2026.
  • Generali Investments CEE left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up 0.03% of Generali Investments CEE's portfolio in Q2 2026, its #332 holding.
  • Generali Investments CEE first reported a position in Teva Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.